Is CellCarta still active?

Yes, CellCarta is currently active.

Where is CellCarta registered?

CellCarta's registered address is Sint-Bavostraat 78, 2610 Antwerpen, Belgium.

How many employees does CellCarta have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), CellCarta reported 242.7 full-time equivalent employees.

What is CellCarta's annual turnover?

CellCarta's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €79,878,333.

Did CellCarta make a profit or a loss?

CellCarta's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €7,698,401.

When did CellCarta last file annual accounts?

CellCarta's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is CellCarta B Corp certified?

We have no B Corp certification on file for CellCarta.

Does CellCarta hold Fairtrade certification?

No, CellCarta does not currently hold Fairtrade certification.

CellCarta

Q: When was CellCarta founded?

CellCarta was founded on 23 Apr 2001, making it 25 years old.

Q: What does CellCarta do?

CellCarta's registered main activities are Diagnostic imaging services and medical laboratory activities, Research and experimental development on other natural sciences and engineering, and Study, development of the production of active ingredients for drug manufacturing.

BE 0474.654.355

Copied!

NV/SA

Status

Active

Founded

23 Apr 2001

Size

Large · 242.7 FTE

Age

25 yrs

Main activity

Diagnostic imaging services and medical laboratory activities

Website

histogenex.com

Activities

3 activities

Diagnostic imaging services and medical laboratory activitiesResearch and experimental development on other natural sciences and engineeringStudy, development of the production of active ingredients for drug manufacturing

Financials

Turnover2025

€79.9M+7.9%

Profit / Loss2025

€7.7M-12.4%

Equity2025

€25.9M+42.4%

2025	2024	2023	2022
€79,878,333+7.9%	€74,025,203+26.3%	€58,617,714+10.4%	€53,081,660
€7,698,401-12.4%	€8,793,487+922.4%	€860,125+111.3%	-€7,599,892
€25,865,408+42.4%	€18,167,006+93.8%	€9,373,519+10.1%	€8,513,394
€34,605,296-12.9%	€39,719,857-2.2%	€40,600,995+13.4%	€35,806,712
€7,290,194-52%	€15,188,452+68%	€9,040,172+76.4%	€5,123,560
242.7+2.7%	236.4+5.1%	225+9%	206.5
€329,124+5.1%	€313,135+20.2%	€260,523+1.3%	€257,054

Frequently asked questions

01What is CellCarta's official registered name?

CellCarta.

02What is CellCarta's enterprise number (VAT number)?

BE 0474.654.355.

03What is CellCarta's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was CellCarta founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€79,878,333+7.9%	€74,025,203+26.3%	€58,617,714+10.4%	€53,081,660
	€23,064,991+14%	€20,228,395+9.3%	€18,501,189+14.5%	€16,155,175
	€11,714,126+10.5%	€10,601,868+199.2%	€3,543,674-30.9%	€5,128,426
	€14,357,547+11.5%	€12,879,479	—	—
	€7,698,401-12.4%	€8,793,487+922.4%	€860,125+111.3%	-€7,599,892
	€2,716,788+8.5%	€2,504,836+13.9%	€2,198,549+13.3%	€1,940,561
Profitability
	18.0%+3.3%	17.4%	—	—
	9.6%-18.9%	11.9%+709.6%	1.5%+110.3%	-14.3%
	29.8%-38.5%	48.4%+427.5%	9.2%+110.3%	-89.3%
	12.7%-16.2%	15.2%+782.6%	1.7%+110%	-17.1%
Solvency
	€60,470,703+4.5%	€57,886,863+15.8%	€49,974,514+12.8%	€44,320,106
	€6,106,463+22.3%	€4,993,739+3.1%	€4,844,363+8.5%	€4,466,097
	€2,697,398+11.9%	€2,410,3770%	€2,410,377+0.4%	€2,401,193
	€25,865,408+42.4%	€18,167,006+93.8%	€9,373,519+10.1%	€8,513,394
	42.8%+36.3%	31.4%+67.3%	18.8%-2.3%	19.2%
	€1,091,770+387.3%	€224,068-62.1%	€591,640-33.9%	€895,421
	0.04+242.2%	0.01-80.5%	0.06-40%	0.11
	€34,605,296-12.9%	€39,719,857-2.2%	€40,600,995+13.4%	€35,806,712
	1.34-38.8%	2.19-49.5%	4.33+3%	4.21
	55.25+78.7%	30.93+252.8%	8.77-77.4%	38.72
Liquidity
	€7,290,194-52%	€15,188,452+68%	€9,040,172+76.4%	€5,123,560
	€5,970,529-1.8%	€6,080,628+17.9%	€5,159,177+18.8%	€4,344,623
	€20,832,380+37%	€15,204,484+60.3%	€9,486,806-11.7%	€10,746,601
	€10,855,763-39.9%	€18,067,201-11.5%	€20,426,828+6.6%	€19,162,698
	€20,396,849-18.4%	€24,986,584-3.3%	€25,845,115+5.4%	€24,519,999
	0.92+43%	0.65+9.9%	0.59-9.2%	0.65
	€4,701,667+296%	€1,187,269+115.9%	-€7,478,905-3.8%	-€7,207,868
Efficiency
	95 days+27%	75 days+26.9%	59 days-20.1%	74 days
	78 days-43.6%	138 days-26.3%	188 days-5%	198 days
	224 days-0.2%	225 days+6.3%	211 days+6%	199 days
	1.61-8.5%	1.76-5.9%	1.87-22.7%	2.42
Profit appropriation
	—	—	—	€0
	€24,803,408+45%	€17,105,006+105.8%	€8,311,519+11.5%	€7,451,394

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€79,878,333+7.9%	€74,025,203+26.3%	€58,617,714+10.4%	€53,081,660
	€23,064,991+14%	€20,228,395+9.3%	€18,501,189+14.5%	€16,155,175
	€11,714,126+10.5%	€10,601,868+199.2%	€3,543,674-30.9%	€5,128,426
	€14,357,547+11.5%	€12,879,479	—	—
	€7,698,401-12.4%	€8,793,487+922.4%	€860,125+111.3%	-€7,599,892
	€2,716,788+8.5%	€2,504,836+13.9%	€2,198,549+13.3%	€1,940,561
Profitability
	18.0%+3.3%	17.4%	—	—
	9.6%-18.9%	11.9%+709.6%	1.5%+110.3%	-14.3%
	29.8%-38.5%	48.4%+427.5%	9.2%+110.3%	-89.3%
	12.7%-16.2%	15.2%+782.6%	1.7%+110%	-17.1%
Solvency
	€60,470,703+4.5%	€57,886,863+15.8%	€49,974,514+12.8%	€44,320,106
	€6,106,463+22.3%	€4,993,739+3.1%	€4,844,363+8.5%	€4,466,097
	€2,697,398+11.9%	€2,410,3770%	€2,410,377+0.4%	€2,401,193
	€25,865,408+42.4%	€18,167,006+93.8%	€9,373,519+10.1%	€8,513,394
	42.8%+36.3%	31.4%+67.3%	18.8%-2.3%	19.2%
	€1,091,770+387.3%	€224,068-62.1%	€591,640-33.9%	€895,421
	0.04+242.2%	0.01-80.5%	0.06-40%	0.11
	€34,605,296-12.9%	€39,719,857-2.2%	€40,600,995+13.4%	€35,806,712
	1.34-38.8%	2.19-49.5%	4.33+3%	4.21
	55.25+78.7%	30.93+252.8%	8.77-77.4%	38.72
Liquidity
	€7,290,194-52%	€15,188,452+68%	€9,040,172+76.4%	€5,123,560
	€5,970,529-1.8%	€6,080,628+17.9%	€5,159,177+18.8%	€4,344,623
	€20,832,380+37%	€15,204,484+60.3%	€9,486,806-11.7%	€10,746,601
	€10,855,763-39.9%	€18,067,201-11.5%	€20,426,828+6.6%	€19,162,698
	€20,396,849-18.4%	€24,986,584-3.3%	€25,845,115+5.4%	€24,519,999
	0.92+43%	0.65+9.9%	0.59-9.2%	0.65
	€4,701,667+296%	€1,187,269+115.9%	-€7,478,905-3.8%	-€7,207,868
Efficiency
	95 days+27%	75 days+26.9%	59 days-20.1%	74 days
	78 days-43.6%	138 days-26.3%	188 days-5%	198 days
	224 days-0.2%	225 days+6.3%	211 days+6%	199 days
	1.61-8.5%	1.76-5.9%	1.87-22.7%	2.42
Profit appropriation
	—	—	—	€0
	€24,803,408+45%	€17,105,006+105.8%	€8,311,519+11.5%	€7,451,394

2025

2024

2023

2022

Income statement

€79,878,333+7.9%

€74,025,203+26.3%

€58,617,714+10.4%

€53,081,660

€23,064,991+14%

€20,228,395+9.3%

€18,501,189+14.5%

€16,155,175

€11,714,126+10.5%

€10,601,868+199.2%

€3,543,674-30.9%

€5,128,426

€14,357,547+11.5%

€12,879,479

—

€7,698,401-12.4%

€8,793,487+922.4%

€860,125+111.3%

-€7,599,892

€2,716,788+8.5%

€2,504,836+13.9%

€2,198,549+13.3%

€1,940,561

Profitability

18.0%+3.3%

17.4%

—

9.6%-18.9%

11.9%+709.6%

1.5%+110.3%

-14.3%

29.8%-38.5%

48.4%+427.5%

9.2%+110.3%

-89.3%

12.7%-16.2%

15.2%+782.6%

1.7%+110%

-17.1%

Solvency

€60,470,703+4.5%

€57,886,863+15.8%

€49,974,514+12.8%

€44,320,106

€6,106,463+22.3%

€4,993,739+3.1%

€4,844,363+8.5%

€4,466,097

€2,697,398+11.9%

€2,410,3770%

€2,410,377+0.4%

€2,401,193

€25,865,408+42.4%

€18,167,006+93.8%

€9,373,519+10.1%

€8,513,394

42.8%+36.3%

31.4%+67.3%

18.8%-2.3%

19.2%

€1,091,770+387.3%

€224,068-62.1%

€591,640-33.9%

€895,421

0.04+242.2%

0.01-80.5%

0.06-40%

0.11

€34,605,296-12.9%

€39,719,857-2.2%

€40,600,995+13.4%

€35,806,712

1.34-38.8%

2.19-49.5%

4.33+3%

4.21

55.25+78.7%

30.93+252.8%

8.77-77.4%

38.72

Liquidity

€7,290,194-52%

€15,188,452+68%

€9,040,172+76.4%

€5,123,560

€5,970,529-1.8%

€6,080,628+17.9%

€5,159,177+18.8%

€4,344,623

€20,832,380+37%

€15,204,484+60.3%

€9,486,806-11.7%

€10,746,601

€10,855,763-39.9%

€18,067,201-11.5%

€20,426,828+6.6%

€19,162,698

€20,396,849-18.4%

€24,986,584-3.3%

€25,845,115+5.4%

€24,519,999

0.92+43%

0.65+9.9%

0.59-9.2%

0.65

€4,701,667+296%

€1,187,269+115.9%

-€7,478,905-3.8%

-€7,207,868

Efficiency

95 days+27%

75 days+26.9%

59 days-20.1%

74 days

78 days-43.6%

138 days-26.3%

188 days-5%

198 days

224 days-0.2%

225 days+6.3%

211 days+6%

199 days

1.61-8.5%

1.76-5.9%

1.87-22.7%

2.42

Profit appropriation

—

€0

€24,803,408+45%

€17,105,006+105.8%

€8,311,519+11.5%

€7,451,394

CellCarta

Activities

Financials

Frequently asked questions

All locations

All locations